Company · CIK 0001766140 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Unicycive Therapeutics, Inc. · UNCY
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 AForm 4/A → | Jul 28, 4:15 pm EDT | Sara Kenkare-MitraDirector | 47,941 | — | — | 47,941 | — | |
| May 14, 2026 AForm 4/A → | Jul 28, 4:15 pm EDT | Sandeep LaumasDirector | 47,941 | — | — | 47,941 | — | |
| May 14, 2026 AForm 4/A → | Jun 15, 5:24 pm EDT | Shalabh K. GuptaCEO, Director | 762,200 | — | — | 762,200 | — | |
| May 14, 2026 AForm 4/A → | Jun 15, 5:24 pm EDT | Sara Kenkare-MitraDirector | 126,300 | — | — | 126,300 | — | amended |
| May 14, 2026 AForm 4/A → | Jun 15, 5:24 pm EDT | Sandeep LaumasDirector | 126,300 | — | — | 126,300 | — | amended |
| May 14, 2026 AForm 4/A → | Jun 15, 5:24 pm EDT | Pramod GuptaEVP, Pharmaceuticals and BD | 169,500 | — | — | 169,500 | — | |
| May 14, 2026 AForm 4/A → | Jun 15, 5:23 pm EDT | John TownsendCFO | 169,500 | — | — | 169,500 | — | |
| May 14, 2026 AForm 4/A → | Jun 15, 5:23 pm EDT | Douglas JermasekEVP, Corporate Strategy | 169,500 | — | — | 169,500 | — |